Answers are grounded in this paper and cite their sources.
Myxovirus A (MxA) is a protein that is specifically induced by treatment with type I cytokines and has proven to be a reliable biomarker of interferon-beta (IFNbeta) bioactivity. IFNbeta-induced MxA can be measured as either protein or mRNA in the blood of IFNbeta-treated patients with MS. In patients with MS who are treated with IFNbeta, loss of the MxA response is caused by high levels of anti-IFNbeta antibodies and is a sensitive marker of lost bioactivity.
No takes yet. Share an insight, caveat, or question.
Pachner et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: